Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Movement Alert|Moderna, Inc. Rises 8.74% in Pre-Market Trading, Multiple Catalysts Including Positive Melanoma Trial and Flu Vaccine Retail Launch

Market Focus
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Moderna (MRNA) Stock Looks Pricey After A 126% Return Yet Sales Stay Strong

Simply Wall St.
·
Aug 17

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.
·
Aug 16

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

TIPRANKS
·
Aug 14

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Aug 13

Stock Track | Moderna Soars Over 5% Intraday on First mRNA Flu Vaccine FDA Approval and Q2 Earnings Beat

Stock Track
·
Aug 13

Movement Alert|Moderna, Inc. Rises 5.17% in Regular Trading, First mRNA Flu Vaccine FDA Approval Combined with Q2 Earnings Beat

Market Focus
·
Aug 12

Stock Track | Moderna Soars 5% in Pre-Market as FDA Approval of First mRNA Flu Vaccine Continues to Drive Gains

Stock Track
·
Aug 10

Movement Alert|Moderna, Inc. Rises 5.15% in Pre-Market Trading, First mRNA Flu Vaccine FDA Approval Continues to Boost Shares

Market Focus
·
Aug 10

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Moderna CEO Stephane Bancel Disposes of 499,246 Shares for $9.56 Million

Reuters
·
Aug 08

Stock Track | Moderna Soars 5.28% Intraday as First mRNA Flu Vaccine Wins FDA Approval

Stock Track
·
Aug 07

Movement Alert|Moderna, Inc. Rises 5.31% in Regular Trading, First mRNA Flu Vaccine Wins FDA Approval

Market Focus
·
Aug 07

Soligenix Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 07

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End

Reuters
·
Aug 07